Dr. Rummana S Aslam, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 |
Dr. Albert Daniel Ardao, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 292 Pequot Ave, #40, New London, CT 06320 Phone: 860-443-8098 |
Mustapha Kemal, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, L&m Physician Association, Inc., New London, CT 06320 Phone: 860-442-0711 Fax: 860-442-0262 |
Dr. Joseph W Peters, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-444-4739 Fax: 860-442-0260 |
News Archive
Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that it has been issued six patents within the last 12 months, bringing the company's total to 15 issued U.S. patents, all of which contain broad claims in the immunoassay space.
The world will experience a significant acceleration in the speed of population aging over the coming years but slow down by mid-century, according to a study by Warren Sanderson, Professor and Co-Chairman of the Department of Economics, Stony Brook University; and colleagues from the World Population Program at the International Institute for Applied Systems Analysis in Austria.
Using a novel method they developed to map chromosome breaks in a model organism, the budding yeast, Wenyi Feng, Ph.D., of Upstate Medical University and her colleagues have discovered new information as to how and where chromosome fragile sites can occur in human DNA. These sites are frequently observed in cancer cells and are responsible for causing genomic rearrangements.
The marker Flattop subdivides the insulin-producing beta cells of the pancreas into those that maintain glucose metabolism and into immature cells that divide more frequently and adapt to metabolic changes.
The Ontario Health Technology Advisory Committee has recommended Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU or MRgFUS) as a possible "cost-effective strategy" and a "safe and effective, noninvasive, uterine-preserving" option for women seeking treatment for uterine fibroids.
› Verified 9 days ago